How to buy Quotient stock

Quotient Limited is a diagnostics & research business based in the US. Quotient shares (QTNT) are listed on the NASDAQ and all prices are listed in US Dollars. Quotient employs 439 staff and has a trailing 12-month revenue of around 0.00.

Quotient share price

Use our graph to track the performance of QTNT stocks over time.

Quotient shares at a glance

• Key figures

Information last updated 2021-03-10.

52-week range	$2.40 - $9.58
50-day moving average	$5.17
200-day moving average	$5.52
Wall St. target price	$12.33
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.73

Buy Quotient shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Quotient stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Quotient Limited by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Quotient financials

Revenue TTM	$42.4 million
Gross profit TTM	$14.9 million
Return on assets TTM	-19.06%
Return on equity TTM	-737.71%
Profit margin	-223.58%
Book value	$0.08
Market capitalisation	$438.9 million

TTM: trailing 12 months

Shorting Quotient shares

There are currently 4.1 million Quotient shares held short by investors – that's known as Quotient's "short interest". This figure is 1.9% down from 4.2 million last month.

There are a few different ways that this level of interest in shorting Quotient shares can be evaluated.

Quotient's "short interest ratio" (SIR)

Quotient's "short interest ratio" (SIR) is the quantity of Quotient shares currently shorted divided by the average quantity of Quotient shares traded daily (recently around 899871.39737991). Quotient's SIR currently stands at 4.58. In other words for every 100,000 Quotient shares traded daily on the market, roughly 4580 shares are currently held short.

However Quotient's short interest can also be evaluated against the total number of Quotient shares, or, against the total number of tradable Quotient shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Quotient's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Quotient shares in existence, roughly 40 shares are currently held short) or 0.0488% of the tradable shares (for every 100,000 tradable Quotient shares, roughly 49 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Quotient.

Find out more about how you can short Quotient stock.

Quotient share dividends

We're not expecting Quotient to pay a dividend over the next 12 months.

Quotient share price volatility

Over the last 12 months, Quotient's shares have ranged in value from as little as $2.395 up to $9.58. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Quotient's is 2.3976. This would suggest that Quotient's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Quotient overview

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology and serological disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company is also developing microarray-based SARS-CoV-2 antibody test for use on the MosaiQ platform for COVID-19. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland. .

Frequently asked questions

• What percentage of Quotient is owned by insiders or institutions?

  Currently 1.82% of Quotient shares are held by insiders and 91.626% by institutions.

• How many people work for Quotient?

  Latest data suggests 439 work at Quotient.

• When does the fiscal year end for Quotient?

  Quotient's fiscal year ends in March.

• Where is Quotient based?

  Quotient's address is: B1, Business Park Terre Bonne, Eysins, Switzerland, 1262

• What is Quotient's ISIN number?

  Quotient's international securities identification number is: JE00BLG2ZQ72

• What is Quotient's CUSIP number?

  Quotient's Committee on Uniform Securities Identification Procedures number is: G73268107